A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2008

Conditions
Acne Vulgaris
Interventions
DRUG

ASC-J9 cream

Topical application to the face twice daily for 12 weeks.

DRUG

placebo

vehicle control applied topically twice daily for 12 weeks

Trial Locations (10)

24501

Education and Research Foundation, Lynchburg

37934

Dermatology Associates, Knoxville

77802

J&S Studies, Inc, Bryan

78759

DermResearch, Inc, Austin

83704

Northwest Clinical Trial, Boise

84124

Dermatology Research Center, Inc, Salt Lake City

87106

Academic Dermatology Associates, Albuquerque

92123

Therapeutics Clinical Research, San Diego

94538

East Bay Dermatology Medical Group, Fremont

07652

TKL Research, Inc, Paramus

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AndroScience Corp

INDUSTRY

NCT00525499 - A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris | Biotech Hunter | Biotech Hunter